Skip to main content

Press Releases

Press release year list 2020 2019 2018 2017 2016 2015 2014 2013 2012
December 05, 2018
ADC Therapeutics Presents Updated Data from Clinical Trials of Novel Antibody Drug Conjugates
Download PDF format download (opens in new window)
November 27, 2018
ADC Therapeutics Announces First Patients Dosed in Phase I/II Clinical Trial of ADCT-602 in Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia
Download PDF format download (opens in new window)
November 14, 2018
ADC Therapeutics Announces Presentations at 60th American Society of Hematology (ASH) Annual Meeting
Download PDF format download (opens in new window)
November 08, 2018
ADC Therapeutics Announces Presentations at the Society for Immunotherapy of Cancer’s (SITC) 33rd Annual Meeting
Download PDF format download (opens in new window)
August 07, 2018
ADC Therapeutics Doses First Patient in Pivotal Clinical Trial of ADCT-402 in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Download PDF format download (opens in new window)
April 25, 2018
ADC Therapeutics Announces the Termination of its ADCT-502 Program Targeting HER2 Expressing Solid Tumors
Download PDF format download (opens in new window)
April 11, 2018
ADC Therapeutics to Present Two New Investigational Antibody-Drug Conjugates at the American Association for Cancer Research (AACR) Annual Meeting
Download PDF format download (opens in new window)